Technical / White Paper


Format: PDF file | Document type: Technical / White Paper | Promoted Content

This content is provided by Recipharm AB, and any views and opinions expressed do not necessarily reflect those of


Recipharm already has experience in serialised production. From our UK facility in Manchester over 40 batches have been delivered from a fully validated line to the Turkish market since 2010.

Serialisation is a complex area and the requirements are likely to develop and change over time. It is not an area that can be ignored regardless of whether the drug being sold is a brand new high value molecule or a commodity generic.

Latest content from Recipharm AB


Paid for and content provided by Recipharm AB

Take steps to stay in the serialization race

As the deadline for drug serialization in the EU looms closer, it’s time to put the topic firmly on your agenda. Learn how to overcome the serialization challenge and simplify compliance.

Related resources from Recipharm AB

Show more

Supplier info centre